Physician Wealth Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.3K Sell
818
-4
-0.5% -$207 0.01% 406
2026
Q1
$41.8K Hold
822
0.01% 435
2025
Q4
$24.2K Hold
822
﹤0.01% 541
2025
Q3
$21.2K Buy
822
+89
+12% +$2.48K ﹤0.01% 565
2025
Q2
$20.2K Hold
733
﹤0.01% 514
2025
Q1
$20.8K Buy
733
+285
+64% +$10.1K ﹤0.01% 476
2024
Q4
$18.6K Buy
+448
New +$21.4K ﹤0.01% 523

Other funds holding MRNA

Physician Wealth Advisors's MRNA Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Moderna (MRNA) stake by 0.49% in Q2 2026, selling an estimated $207 and leaving 818 shares worth $57.3K. The position accounts for 0.01% of the portfolio, ranked #406.

Physician Wealth Advisors first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 299 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Physician Wealth Advisors held 818 shares of Moderna worth $57.3K as of Q2 2026.
  • Physician Wealth Advisors sold 4 Moderna shares in Q2 2026, an estimated $207.
  • Moderna made up 0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #406 holding.
  • Physician Wealth Advisors first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 299 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.